東風股份(601515.SH)：擬收購常州華健藥用包裝材料70%股權
格隆匯 9 月 7日丨東風股份(601515.SH)公佈，公司與温州弘峯企業管理合夥企業(有限合夥)、温州隆暢企業管理合夥企業(有限合夥)、温州溢宸企業管理合夥企業(有限合夥)、常州市弘晁創業投資合夥企業(有限合夥)、顧鎖娟、陳祥華、顧鎖忠及常州市華健藥用包裝材料有限公司簽署《關於收購常州市華健藥用包裝材料有限公司70%股權之股權轉讓協議》，以人民幣11025萬元的價格受讓温州弘峯企業管理合夥企業(有限合夥)、温州隆暢企業管理合夥企業(有限合夥)、温州溢宸企業管理合夥企業(有限合夥)持有的常州市華健藥用包裝材料有限公司合計70%股權。
華健藥包主要從事藥用SP複合膜、藥用包裝鋁箔、成型衝壓複合硬片(包括冷衝壓成型鋁、熱帶型泡罩鋁)等的研發、生產和銷售，於2019年獲得中國醫藥包裝協會頒發的“優秀會員獎”。
公司此次擬同時收購華健藥包70%股權及重慶首鍵藥用包裝材料有限公司(“首鍵藥包”)75%股權，並實現對兩家公司的控股，華健藥包及首鍵藥包均為原新三板掛牌企業，在行業內具備較強的規模及實力。華健藥包主要生產I類藥用包裝鋁箔、藥用SP複合膜、成型衝壓複合硬片(冷衝壓成型鋁、熱帶泡罩鋁)材料，首鍵藥包主要從事I類醫藥用瓶蓋研發、生產、銷售，主要產品包括口服液、輸液瓶用易刺鋁蓋、鋁塑組合蓋和撕拉鋁蓋等產品，兩者與千葉藥包在產品品類上相互補充，進一步拓展公司醫藥包裝業務的產品類別，並通過千葉藥包、華健藥包及首鍵藥包在生產、銷售及客户資源上的有效協同，有望進一步做強做大公司的醫藥包裝業務板塊，提升公司印刷包裝產業板塊的整體規模及市場競爭力，加快推進“大包裝與大消費產業雙輪驅動發展”戰略的實施。
此次收購完成後，公司將通過產業鏈協同、資金支持等優勢為華健藥包及首鍵藥包未來的發展賦能，提升其經營效益，預計將對公司財務狀況及經營指標帶來積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
